Dr.Harold Koplewicz used the NYTimes to name drop Delcath Systems, Inc.

Dr.Harold Koplewicz, recently written about HERE and HERE regarding the NYTimes Q & A "Ask a child psychiatrist" advice column apparently, slipped in a bit of free advertising for Delcath Systems, Inc., of which he is Chairman of the Board.

I find this even more disturbing, considering the association of PAXIL study 329 (co-author)and the 'Ransom Notes' campaign associated with Dr. Harold Koplewicz.

From the a Delcath forum, open to the public for viewing, because I found it by Googling his name and DCTH, when I saw several stat reads come through my reader using that search term (the stock symbol DCTH, for Delcath, Systems Inc.)

Here's what this forum member wrote:


http://www.investorvillage.com/smbd.asp?mb=2420&mn=24096&pt=msg&mid=9070497



"Dr Koplewicz.........The Sly Name Dropper

http://cityroom.blogs.nytimes.com/2010/05/26/answers-about-child-psychiatry/

Any publicity is good publicity and it doesn't get much better than a mention in the New York Time. A little interview with our Chairman of the Board, Dr Koplewicz. An interview dealing with his specialty, child psychiatry and you wouldn't expect he could get a mention of DCTH in but he does.

Here's one his answers.....

"Neither I nor The Child Study Center Foundation receive funds from pharmaceutical companies that produce psychiatric medications. In fact, the charter of CSCF stipulates that we will never accept funding from a pharmaceutical company. In the interest of full disclosure, I have been chairman of the board of Delcath Systems Inc., since 2007. Delcath is a publicly held company developing a device that will enable physicians to deliver anti-cancer drugs to the liver without exposing the rest of a given patient’s body"

I realize its not much but this is the New York Times. He slipped in that we are a publicly held company and a very brief synopsis of what we do. Hopefully this brief mention will get the attention of a few readers and the will follow up with a little DD. Honestly, our company has so much prospect that it will sell itself to anyone who does even a little bit of investigation.

I expect that once the full results are made public at ASCO, Dr Koplewicz will bring to bear his full relationship with the media. We are very fortunate to have such an amazing caliber of recognized experts within such a little company."
--Delcath forum discussing stock, profit, Koplewicz and more

---

My OPINION

I THINK WE NEED TO SERIOUSLY QUESTION THE INTEGRITY OF THE NY TIMES AND WHO THEY CHOOSE TO ANSWER QUESTIONS FROM "EXPERTS".

THIS IS A CONFLICT OF INTEREST, AND AN ABUSE OF THE NYTIMES, abuse of power, and a fine example of the all for profit pharmaceutical, unethical and corrupt association psychiatry has with making money off of innocent victims. this is my opinion.

*American Society of Clinical Oncology (ASCO) conference, which featured trial results from big-cap pharma companies for revolutionary treatments for leukemia, skin and lung cancers.

*Dr.Harold Koplewicz can also be found on Face Book

http://www.facebook.com/HaroldKoplewiczMD

and

Twitter http://twitter.com/DrKoplewicz

Fear mongering and pro-drug treatment "Ransom Notes"

*DTC advertising from the "Ransom Notes" campaign

NYTimes-Ransom-Note Ads About Children’s Health Are Canceled

.."..used the device of ransom notes to deliver ominous messages concerning disorders like autism, depression, bulimia and attention-deficit hyperactivity disorder."